Article | September 8, 2016

7 Steps For A Reproducible Cycle Development Plan

Source: Parenteral Drug Association (PDA)

By Stefan Kleinmann PhD, Matthias Scheu, Christian Fecht, METALL+PLASTIC

Decontamination cycle development takes place between the completed operational qualification and the subsequent process validation. It also determines the parameters for a successful, effective and repeatable decontamination process that complies with the requirements of both regulatory agencies and end users. The PIC/S guide for isolators states that an isolator decontamination cycle using a minimum 6-log spore reduction is often applied (1). During routine operation, pharmaceutical isolators and material transfer chambers use decontamination cycles to yield a theoretical 10- to 12-log spore reduction for additional safety.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Parenteral Drug Association (PDA)